Aberrant STAT3 activation is preferentially present in GSCs relative to differentiated GBM cells, and its inhibition suppresses the self-renewal capacity of GSCs (36), suggesting that inhibition of the STAT3 signaling pathway may have significant therapeutic potential. Here, STAT3 is linked to glioblastoma.